MDXG 8-K SEC Filing Analysis

Latest settled — T+20d

MDXG ▲ +2.62% at T+20d

SHORT call ✗ call lost -2.62% · α vs SPY +3.19% · entry $3.43 → $3.52

Next anchor: T+60d in 5w

Last close $3.70 (close Jun 8) · -7.87% from $3.43 entry (call sign-flipped)

Entry anchored
Apr 15, 03:59 PM ET
via Databento tick

T+1d

-0.29%

call +0.29% · α +1.51%

$3.42

settled 8w ago

T+5d

-2.33%

call +2.33% · α +3.32%

$3.35

settled 7w ago

T+20d

+2.62%

call -2.62% · α +3.19%

$3.52

settled 27d ago

T+60d

—

call — · α —

—

in 5w

Price Chart

Loading chart...

Executive Summary

MiMedx Group announced a cost reduction initiative including the elimination of the Chief Operating Officer position and salary reductions for executives, citing slow recovery in the Wound Care market. The company expects $40 million in annualized savings and a one-time $4 million restructuring charge.

Actionable Insight

The cost reductions and executive departures suggest ongoing challenges in the Wound Care segment. Traders should monitor the upcoming quarterly conference call for more details on financial performance and whether these measures will improve profitability.

Key Facts

Ricci Whitlow departed as Chief Operating Officer
CEO Joe Capper's base salary reduced by 20%
Other named executive officers' base salaries reduced by 10%
Company expects $40 million in annualized savings
One-time restructuring charge of $4 million expected
Wound Care business recovering slowly from Medicare reimbursement reduction

Financial Impact

Annualized savings of $40 million with a one-time $4 million restructuring charge

operating expensesrestructuring chargeexecutive compensation

Risk Factors

Slow recovery in Wound Care business
One-time restructuring charge of $4 million
Potential negative impact on employee morale

Market Snapshot

Exchange

Nasdaq

Sector

Surgical & Medical Instruments & Apparatus

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

Document	Accession Number
8-K Filing (Primary)	0001376339-26-000021
Exhibit: ex-991restructuringpress.htm	0001376339-26-000021
Document: 0001376339-26-000021-index-headers.html	0001376339-26-000021
Document: 0001376339-26-000021-index.html	0001376339-26-000021
Document: 0001376339-26-000021.txt	0001376339-26-000021

4 reports for MDXG

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for MDXG — sortable, filterable
	Type				Now
Jun 2, 2026 8d ago	Court Ruling BULLISH ★ 5/10	$3.57 $3.61	▲ +1.12%	▲ +1.81%	$3.70 (+3.64%)
Apr 29, 2026 5w ago	DEFA14A NEUTRAL ★ 3/10	$3.36 $3.36	· 0.00%	▼ −0.22%	$3.70 (+10.12%)
Apr 22, 2026 6w ago	Press Release NEUTRAL ★ 3/10	$3.31 $3.35	▲ +1.21%	▲ +1.60%	$3.70 (+11.78%)
Apr 16, 2026 7w ago	8-K BEARISH ★ 7/10	$3.43 $3.42	▲ +0.29%	▲ +1.51%	$3.70 (−7.87%)

US Market Status

Market Closed — Opens in 6h 55m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access